Science
Mechanism of Action
This compound exerts its primary action as a moderately potent, yet highly selective, antagonist of alpha-2-adrenoceptors. This mechanism is fundamentally pharmacological and does not have typically described direct benefits relevant to cosmetic skincare applications.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Imiloxan HCl is not recognized as a cosmetic ingredient, thus common 'dusting' practices or associated thresholds are not applicable or established.
The Formula
Formulation
Stability
General recommendations suggest storing desiccated at room temperature. Specific stability data pertinent to its incorporation into cosmetic formulations, including optimal pH ranges, are not available.
Safety
Safety Profile
There has been no formal safety assessment conducted by the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS) regarding its use as a cosmetic ingredient. The FDA status for cosmetic application is not explicitly defined, with the substance primarily classified as a research chemical or drug.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Imiloxan HCl is identified as a research chemical/drug with no established cosmetic benefits, clinical efficacy, or formal safety assessment for skincare use, rendering it unsuitable for formulations.
Related
Similar Ingredients
Finding similar ingredients…